Oat Avenanthramide‐C Alleviates DSS‐Induced Colitis Through Regulating Intestinal Immune Activity and Gut Microbiota in Mice
Molecular Nutrition & Food Research · 2025-11 · 69 (22)
DOI: 10.1002/mnfr.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 02.09.2025. Verfasst von Gaoqi Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, ortho-Aminobenzoates, Avena. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Nova Program, the Project of Cultivation for young topnotch Talents of Beijing Municipal Institutions.
Abstract (Originalsprache)
Oat avenanthramide‐C (AVN‐C) exhibits notable anti‐inflammatory and antioxidant properties, while its potential effects on inflammatory bowel disease (IBD) remain unclear. This study aimed to investigate the impact of AVN‐C on dextran sulfate sodium (DSS)‐induced colitis and explore the underlying mechanisms. Male C57BL/6J mice were treated with AVN‐C (5 and 10 mg/kg BW) for 1 week prior to receiving 2.5% DSS in drinking water for 7 days to induce colitis. AVN‐C treatment continued during the DSS period. The results showed that AVN‐C ameliorated DSS‐induced colitis symptoms and intestinal barrier dysfunction. AVN‐C treatment also reduced neutrophil infiltration and prevented neutrophil extracellular traps (NETs) formation. Moreover, AVN‐C elevated the relative abundance of Firmicutes and Akkermansia , while reducing Proteobacteria and Escherichia‐Shigella , thereby shifting the gut microbial composition toward a more favorable state associated with reduced inflammation. Meanwhile, AVN‐C consumption significantly enhanced intestinal immune activity and maintained gut microbiota balance by modulating primary bile acid biosynthesis through the FXR‐SHP‐NF‐κB signaling pathway. Collectively, AVN‐C exhibited a protective effect against DSS‐induced colitis by modulating neutrophil function, gut microbiota, and bile acid metabolism. These findings highlight the potential of oat AVN‐C as a therapeutic strategy for IBD, offering valuable insights into gastrointestinal health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, China.
- National Center of Technology Innovation for Grain Industry (Comprehensive Utilization of Edible by-Products), Beijing Technology & Business University, Beijing, China.
Förderung
- National Key Research and Development Program of China
- Beijing Nova Program
- the Project of Cultivation for young topnotch Talents of Beijing Municipal Institutions
- Youth Talent program of National Food and Strategic Reserves
- Research Foundation for Youth Scholars of Beijing Technology and Business University
Zitieren
APA
Ye, G., Li, G., Wang, Z., Wang, Z., Wang, J., & Liu, J. (2025). Oat Avenanthramide‐C Alleviates DSS‐Induced Colitis Through Regulating Intestinal Immune Activity and Gut Microbiota in Mice. Molecular Nutrition & Food Research, 69(22). https://doi.org/10.1002/mnfr.70250
Vancouver
Ye G, Li G, Wang Z, Wang Z, Wang J, Liu J. Oat Avenanthramide‐C Alleviates DSS‐Induced Colitis Through Regulating Intestinal Immune Activity and Gut Microbiota in Mice. Molecular Nutrition & Food Research. 2025;69(22). doi:10.1002/mnfr.70250
BibTeX
@article{Ye2025,
author = {Ye, Gaoqi and Li, Genying and Wang, Ziyuan and Wang, Zongwei and Wang, Jing and Liu, Jie},
title = {Oat Avenanthramide‐C Alleviates DSS‐Induced Colitis Through Regulating Intestinal Immune Activity and Gut Microbiota in Mice},
journal = {Molecular Nutrition & Food Research},
year = {2025},
volume = {69},
number = {22},
doi = {10.1002/mnfr.70250}
}
EUVIMED